PT2486051T - Preparação farmacêutica compreendendo hcg recombinante - Google Patents

Preparação farmacêutica compreendendo hcg recombinante

Info

Publication number: PT2486051T
Authority: PT; Portugal
Prior art keywords: pharmaceutical preparation; recombinant hcg; hcg; recombinant; pharmaceutical
Prior art date: 2009-10-05

Application number

PT107630006T

Other languages

English (en)

Portuguese (pt)

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-05

Filing date

2010-10-04

Publication date

2020-06-17

2010-10-04 Application filed by Ferring Bv filed Critical Ferring Bv

2020-06-17 Publication of PT2486051T publication Critical patent/PT2486051T/pt

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PT107630006T 2009-10-05 2010-10-04 Preparação farmacêutica compreendendo hcg recombinante PT2486051T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP09252360		2009-10-05

Publications (1)

Publication Number	Publication Date
PT2486051T true PT2486051T (pt)	2020-06-17

Family

ID=41471027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT107630006T PT2486051T (pt)	2009-10-05	2010-10-04	Preparação farmacêutica compreendendo hcg recombinante

Country Status (25)

Country	Link
US (5)	US8975226B2 (ru)
EP (2)	EP2486051B1 (ru)
JP (6)	JP6176924B2 (ru)
KR (7)	KR20170133531A (ru)
CN (1)	CN107050434B (ru)
AR (2)	AR079876A1 (ru)
AU (1)	AU2010304922B2 (ru)
BR (1)	BR112012007990A2 (ru)
CA (1)	CA2776790A1 (ru)
DK (1)	DK2486051T3 (ru)
ES (1)	ES2798258T3 (ru)
HR (1)	HRP20200941T1 (ru)
HU (1)	HUE050793T2 (ru)
IL (3)	IL218548A (ru)
IN (1)	IN2012DN02073A (ru)
JO (1)	JOP20200039A1 (ru)
LT (1)	LT2486051T (ru)
MX (1)	MX2012003951A (ru)
PL (1)	PL2486051T3 (ru)
PT (1)	PT2486051T (ru)
RS (1)	RS60413B1 (ru)
RU (2)	RU2724528C2 (ru)
SI (1)	SI2486051T1 (ru)
TW (2)	TWI604850B (ru)
WO (1)	WO2011042688A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI488640B (zh) *	2008-04-16	2015-06-21	Ferring Int Ct Sa	藥學製劑
TWI604850B (zh) *	2009-10-05	2017-11-11	菲瑞茵國際中心股份有限公司	藥學製劑
CA3163525A1 (en)	2011-03-31	2012-10-04	Ferring Bv.	Pharmaceutical preparation
WO2012168680A1 (en) *	2011-06-06	2012-12-13	Ferring B.V.	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) *	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
AU2012340501A1 (en) *	2011-12-19	2013-07-11	Grifols, S.A.	Compositions, methods, and kits for preparing sialylated recombinant proteins
ES2784510T3 (es)	2012-12-10	2020-09-28	Seikagaku Kogyo Co Ltd	Método para producir un nuevo Factor C recombinante, método para mitigar la inhibición de la reacción en ensayos de endotoxina, y método para medir endotoxina
JP2018500934A (ja) *	2014-12-22	2018-01-18	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	Ｃｍｐ依存性シアリダーゼ活性
BR112017016895A2 (pt)	2015-04-24	2018-03-27	Ferring Bv	processo de produção de gonadotrofina
ES2770860T3 (es)	2015-06-26	2020-07-03	Ferring Bv	Métodos de purificación y/o inactivación viral
WO2019211153A1 (en)	2018-04-30	2019-11-07	Ferring B.V.	Composition for controlled ovarian stimulation
US20210244821A1 (en) *	2020-02-05	2021-08-12	Novartis Ag	Cho cell expressed het il-15
CN116199742A (zh) *	2022-07-06	2023-06-02	华兰基因工程有限公司	一种重组人绒毛膜***Fc融合蛋白制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4840896A (en) *	1983-11-02	1989-06-20	Integrated Genetics, Inc.	Heteropolymeric protein
DK49987A (da) *	1987-01-30	1988-07-31	Nordisk Gentofte	Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
IT1206302B (it)	1987-06-26	1989-04-14	Serono Cesare Ist Ricerca	Ormone follicolo-stimolante urinario
KR100377967B1 (ko) *	1995-03-21	2003-06-12	어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이.	Hcg액상조성물
TW518235B (en) *	1997-01-15	2003-01-21	Akzo Nobel Nv	A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
PT1775346E (pt)	1997-06-25	2009-08-25	Merck Serono Sa	Análogos de hormonas glicoproteicas reticulados com ligações dissulfureto, sua preparação e utilização
US6500627B1 (en)	1998-02-03	2002-12-31	The Trustees Of Columbia University In The City Of New York	Methods for predicting pregnancy outcome in a subject by HCG assay
AU4592800A (en)	1999-05-07	2000-11-21	Applied Research Systems Ars Holding N.V.	Gonadotrophins
HU228935B1 (en) *	2000-02-22	2013-06-28	Serono Lab	Process of purification of hcg and recombinant hcg purified by that method
MXPA04002256A (es)	2001-09-12	2004-07-23	Applied Research Systems	Uso de gonadotropina corionica humana (gch) en hiperestimulacion ovarica controlada.
DK1438336T3 (da)	2001-10-22	2006-10-02	Applied Research Systems	Gonadotropiner til follikeldannelse
CA2756610C (en) *	2001-10-29	2015-08-25	Crucell Holland B.V.	Methods for producing proteins having n-linked glycans comprising (sialyl-) lewis x or lacdinac structures
AU2002224199A1 (en) *	2001-10-29	2003-06-23	Crucell Holland B.V.	Methods and means for producing proteins with predetermined post-translational modifications
CN1374525A (zh) *	2001-12-31	2002-10-16	陕西超英生物医学研究开发有限公司	一种抗体芯片、其制备技术及其检测方法
BRPI0409229A (pt)	2003-04-01	2006-03-28	Applied Research Systems	inibidores das fosfodiesterases na infertilidade
EP2338333B1 (en) *	2003-04-09	2017-09-06	ratiopharm GmbH	Glycopegylation methods and proteins/peptides produced by the methods
US20040248784A1 (en) *	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
WO2005017130A2 (en) *	2003-08-18	2005-02-24	Glycotope Gmbh	Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof
US8431355B2 (en)	2004-02-04	2013-04-30	Universite De Provence Aix-Marseille 1	Process for screening glycoform-specific antibodies
WO2005080585A1 (en) *	2004-02-13	2005-09-01	Glycotope Gmbh	Highly active glycoproteins-process conditions and an efficient method for their production
WO2006094810A2 (en) *	2005-03-11	2006-09-14	Fresenius Kabi Deutschland Gmbh	Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
US20070033927A1 (en) *	2005-08-15	2007-02-15	Homby Michael J	Automotive diesel exhaust HC dosing valve
RU2309411C2 (ru) *	2005-11-24	2007-10-27	Ростовский НИИ акушерства и педиатрии МЗ РФ	Способ отбора пациенток с синдромом "пустых" фолликулов для проведения программы эко и пэ донорскими ооцитами
KR100809945B1 (ko) *	2006-02-01	2008-03-05	대한민국	인체장내정상세균총 특이반응 ｄｎａ칩 및 이를 이용한인체장내정상세균총의 변화에 의한 인체 위해성의 평가방법
JP2009544327A (ja) *	2006-07-21	2009-12-17	ノヴォノルディスクアー／エス	Ｏ−結合型グリコシル化配列によるペプチドのグリコシル化
US20100075375A1 (en) *	2006-10-03	2010-03-25	Novo Nordisk A/S	Methods for the purification of polypeptide conjugates
TWI488640B (zh)	2008-04-16	2015-06-21	Ferring Int Ct Sa	藥學製劑
TWI604850B (zh) *	2009-10-05	2017-11-11	菲瑞茵國際中心股份有限公司	藥學製劑
CA3163525A1 (en) *	2011-03-31	2012-10-04	Ferring Bv.	Pharmaceutical preparation
JO3092B1 (ar) *	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض

2010
- 2010-09-27 TW TW104140348A patent/TWI604850B/zh active
- 2010-09-27 TW TW099132570A patent/TWI532495B/zh active
- 2010-10-04 US US13/500,274 patent/US8975226B2/en active Active
- 2010-10-04 RS RS20200698A patent/RS60413B1/sr unknown
- 2010-10-04 RU RU2016118236A patent/RU2724528C2/ru active
- 2010-10-04 KR KR1020177034392A patent/KR20170133531A/ko not_active IP Right Cessation
- 2010-10-04 LT LTEP10763000.6T patent/LT2486051T/lt unknown
- 2010-10-04 JP JP2012532657A patent/JP6176924B2/ja active Active
- 2010-10-04 DK DK10763000.6T patent/DK2486051T3/da active
- 2010-10-04 HU HUE10763000A patent/HUE050793T2/hu unknown
- 2010-10-04 CN CN201610832288.8A patent/CN107050434B/zh active Active
- 2010-10-04 WO PCT/GB2010/001854 patent/WO2011042688A1/en active Application Filing
- 2010-10-04 AU AU2010304922A patent/AU2010304922B2/en active Active
- 2010-10-04 KR KR1020197016021A patent/KR102213154B1/ko active IP Right Grant
- 2010-10-04 KR KR1020217003233A patent/KR20210014767A/ko not_active IP Right Cessation
- 2010-10-04 PT PT107630006T patent/PT2486051T/pt unknown
- 2010-10-04 RU RU2012112907/10A patent/RU2588650C2/ru active
- 2010-10-04 KR KR1020237001308A patent/KR20230012104A/ko not_active Application Discontinuation
- 2010-10-04 PL PL10763000T patent/PL2486051T3/pl unknown
- 2010-10-04 IN IN2073DEN2012 patent/IN2012DN02073A/en unknown
- 2010-10-04 KR KR1020127008827A patent/KR101804479B1/ko active IP Right Grant
- 2010-10-04 ES ES10763000T patent/ES2798258T3/es active Active
- 2010-10-04 KR KR1020217037028A patent/KR102489143B1/ko active IP Right Grant
- 2010-10-04 SI SI201032015T patent/SI2486051T1/sl unknown
- 2010-10-04 KR KR1020197007226A patent/KR101987982B1/ko active IP Right Grant
- 2010-10-04 EP EP10763000.6A patent/EP2486051B1/en active Active
- 2010-10-04 EP EP19190372.3A patent/EP3611185A1/en active Pending
- 2010-10-04 BR BR112012007990A patent/BR112012007990A2/pt not_active Application Discontinuation
- 2010-10-04 CA CA2776790A patent/CA2776790A1/en active Pending
- 2010-10-04 MX MX2012003951A patent/MX2012003951A/es active IP Right Grant
- 2010-10-05 AR ARP100103608A patent/AR079876A1/es not_active Application Discontinuation
2012
- 2012-03-08 IL IL218548A patent/IL218548A/en active IP Right Grant
2014
- 2014-05-21 US US14/283,904 patent/US9676835B2/en active Active
2015
- 2015-11-09 JP JP2015219480A patent/JP6310440B2/ja active Active
2017
- 2017-02-23 IL IL250733A patent/IL250733B/en active IP Right Grant
- 2017-05-03 US US15/586,010 patent/US10526390B2/en active Active
- 2017-10-24 JP JP2017205012A patent/JP6580104B2/ja active Active
2019
- 2019-06-20 IL IL267556A patent/IL267556A/en unknown
- 2019-08-27 JP JP2019154226A patent/JP7292153B2/ja active Active
- 2019-12-10 US US16/709,810 patent/US11292824B2/en active Active
2020
- 2020-02-17 JO JOP/2020/0039A patent/JOP20200039A1/ar unknown
- 2020-06-12 HR HRP20200941TT patent/HRP20200941T1/hr unknown
2021
- 2021-07-12 JP JP2021114833A patent/JP7196244B2/ja active Active
2022
- 2022-03-30 US US17/709,296 patent/US20220340634A1/en active Pending
- 2022-05-27 AR ARP220101408A patent/AR125991A2/es unknown
2023
- 2023-02-22 JP JP2023025781A patent/JP2023075144A/ja active Pending

Also Published As

Publication number	Publication date
EP3611185A1 (en)	2020-02-19
WO2011042688A1 (en)	2011-04-14
JP2018076296A (ja)	2018-05-17
US10526390B2 (en)	2020-01-07
IL250733B (en)	2019-07-31
ES2798258T3 (es)	2020-12-10
JP2013506708A (ja)	2013-02-28
BR112012007990A2 (pt)	2017-07-25
JP7196244B2 (ja)	2022-12-26
AU2010304922A1 (en)	2012-03-29
IN2012DN02073A (ru)	2015-08-21
KR20210014767A (ko)	2021-02-09
CN102549011A (zh)	2012-07-04
HRP20200941T1 (hr)	2020-09-18
KR20120094909A (ko)	2012-08-27
TW201632198A (zh)	2016-09-16
JP6310440B2 (ja)	2018-04-11
EP2486051A1 (en)	2012-08-15
TW201113030A (en)	2011-04-16
JP2021176867A (ja)	2021-11-11
US9676835B2 (en)	2017-06-13
AR125991A2 (es)	2023-08-30
KR20190067256A (ko)	2019-06-14
DK2486051T3 (da)	2020-06-22
AR079876A1 (es)	2012-02-29
KR20210141771A (ko)	2021-11-23
CA2776790A1 (en)	2011-04-14
PL2486051T3 (pl)	2020-09-07
RS60413B1 (sr)	2020-07-31
MX2012003951A (es)	2012-05-29
US20220340634A1 (en)	2022-10-27
RU2588650C2 (ru)	2016-07-10
RU2724528C2 (ru)	2020-06-23
IL267556A (en)	2019-08-29
JP6176924B2 (ja)	2017-08-09
CN107050434A (zh)	2017-08-18
SI2486051T1 (sl)	2020-08-31
JP6580104B2 (ja)	2019-09-25
KR20230012104A (ko)	2023-01-25
US20180030107A1 (en)	2018-02-01
LT2486051T (lt)	2020-07-10
RU2016118236A (ru)	2018-10-29
KR101987982B1 (ko)	2019-06-11
JP2020000246A (ja)	2020-01-09
JP2023075144A (ja)	2023-05-30
IL250733A0 (en)	2017-04-30
KR102213154B1 (ko)	2021-02-05
HUE050793T2 (hu)	2021-01-28
US20130023476A1 (en)	2013-01-24
AU2010304922B2 (en)	2014-11-06
RU2016118236A3 (ru)	2019-09-18
TWI532495B (zh)	2016-05-11
KR20170133531A (ko)	2017-12-05
KR20190028823A (ko)	2019-03-19
KR101804479B1 (ko)	2017-12-05
IL218548A0 (en)	2012-05-31
US20200247863A1 (en)	2020-08-06
US11292824B2 (en)	2022-04-05
US8975226B2 (en)	2015-03-10
JP2016074680A (ja)	2016-05-12
TWI604850B (zh)	2017-11-11
EP2486051B1 (en)	2020-03-25
CN107050434B (zh)	2021-07-27
RU2012112907A (ru)	2013-11-10
JP7292153B2 (ja)	2023-06-16
US20140249082A1 (en)	2014-09-04
IL218548A (en)	2017-03-30
JOP20200039A1 (ar)	2022-10-30
KR102489143B1 (ko)	2023-01-13

Publication	Publication Date	Title
IL267556A (en)	2019-08-29	A pharmaceutical preparation containing recombinant hcg
HK1231408A1 (zh)	2017-12-22	藥物組合物
HK1169960A1 (en)	2013-02-15	Pharmaceutical formulation
EP2379077A4 (en)	2013-09-11	PHARMACEUTICAL COMPOSITION
IL220097A (en)	2017-03-30	Pharmaceutical preparation containing oligopeptides
ZA201104348B (en)	2012-02-29	Pharmaceutical preparation
PL2496596T3 (pl)	2017-08-31	Peptydy terapeutyczne
GB0815972D0 (en)	2008-10-08	Pharmaceutical preparation
GB0908515D0 (en)	2009-06-24	Peptide
HRP20141173T1 (hr)	2015-01-30	Medikament koji sadrži miramistin
ZA201203722B (en)	2013-08-28	Peptide
GB0922537D0 (en)	2010-02-10	Pharmaceutical preparation
GB0919650D0 (en)	2009-12-23	Pharmaceutical composition
GB201115173D0 (en)	2011-10-19	Pharmaceutical preparation
GB201115179D0 (en)	2011-10-19	Pharmaceutical preparation
GB0906971D0 (en)	2009-06-03	Pharmaceutical preparation
GB0910772D0 (en)	2009-08-05	Pharmaceutical
PL390620A1 (pl)	2011-09-12	Preparat farmaceutyczny
GB0909494D0 (en)	2009-07-15	Neuroprotective peptide
IL214496A0 (en)	2011-09-27	Short b-defensin-derived peptides
GB0903318D0 (en)	2009-04-08	Medicament
GB0901902D0 (en)	2009-03-11	Medicament